ReviewJournal of clinical medicine2023

Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence.

Athina Dimosiari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.